Is the glutamine story over?

Area of Science:

• Clinical Nutrition
• Amino Acid Metabolism
• Critical Care Medicine

Background:

• Glutamine is considered a conditionally indispensable amino acid for critically ill patients.
• International guidelines have recommended glutamine supplementation for this population.
• Emerging data suggest glutamine supplementation may not be universally beneficial.

Purpose of the Study:

• To review the controversy surrounding glutamine supplementation in critically ill patients.
• To analyze the evidence for and against indiscriminate glutamine use.
• To provide a viewpoint on the current understanding of glutamine's role in critical illness.

Main Methods:

• Review of recent studies and meta-analyses on glutamine supplementation.
• Analysis of existing clinical guidelines and treatment protocols.
• Discussion of conflicting data and arguments regarding glutamine's efficacy and safety.

Main Results:

• Indiscriminate glutamine supplementation in critically ill patients may lead to harm.
• Recent evidence indicates potential adverse effects rather than benefits.
• Current recommendations may not account for individual patient variability.

Conclusions:

• The indiscriminate use of glutamine supplementation in critically ill patients is questionable.
• A more targeted approach to glutamine therapy is warranted.
• Further research is needed to clarify the specific role and safety of glutamine in critical care.